Clinical Research Directory
Browse clinical research sites, groups, and studies.
ESWT for Primary Lipedema
Sponsor: Fatih Bagcier
Summary
This randomized controlled clinical trial aims to evaluate the effectiveness of extracorporeal shockwave therapy (ESWT) when added to standard conservative treatment in women with primary lipedema. Participants will be randomly assigned to receive either standard conservative therapy alone or standard therapy combined with radial ESWT. The study will assess changes in pain intensity (VAS), limb circumference measurements, quality of life (SF-36), and patient satisfaction over an 8-week period. Evaluations will be performed at baseline, at the end of the 4-week treatment phase, and at 4-week follow-up. This trial seeks to provide evidence on whether ESWT offers additional clinical benefit in the management of primary lipedema.
Official title: Extracorporeal Shockwave Therapy for Primary Lipedema: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-12-01
Completion Date
2026-08-01
Last Updated
2025-11-20
Healthy Volunteers
No
Conditions
Interventions
Standard Conservative Therapy
Manual lymphatic drainage, pneumatic compression, Class II compression garments, and a home-based exercise program.
radial ESWT
adial extracorporeal shockwave therapy using a BTL device (2.0-2.5 bar, 12 Hz, 1000 shocks per region, 20-mm head), twice weekly for 4 weeks (8 sessions).